PMID- 19997642 OWN - NLM STAT- MEDLINE DCOM- 20100317 LR - 20220408 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 4 IP - 12 DP - 2009 Dec 4 TI - Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PG - e8158 LID - 10.1371/journal.pone.0008158 [doi] LID - e8158 AB - Inflammation affects the formation and the progression of various vitreoretinal diseases. We performed a comprehensive analysis of inflammatory immune mediators in the vitreous fluids from total of 345 patients with diabetic macular edema (DME, n = 92), proliferative diabetic retinopathy (PDR, n = 147), branch retinal vein occlusion (BRVO, n = 30), central retinal vein occlusion (CRVO, n = 13) and rhegmatogenous retinal detachment (RRD, n = 63). As a control, we selected a total of 83 patients with either idiopathic macular hole (MH) or idiopathic epiretinal membrane (ERM) that were free of major pathogenic intraocular changes, such as ischemic retina and proliferative membranes. The concentrations of 20 soluble factors (nine cytokines, six chemokines, and five growth factors) were measured simultaneously by multiplex bead analysis system. Out of 20 soluble factors, three factors: interleukin-6 (IL-6), interleukin-8 (IL-8), and monocyte chemoattractant protein-1 (MCP-1) were significantly elevated in all groups of vitreoretinal diseases (DME, PDR, BRVO, CRVO, and RRD) compared with control group. According to the correlation analysis in the individual patient's level, these three factors that were simultaneously increased, did not show any independent upregulation in all the examined diseases. Vascular endothelial growth factor (VEGF) was significantly elevated in patients with PDR and CRVO. In PDR patients, the elevation of VEGF was significantly correlated with the three factors: IL-6, IL-8, and MCP-1, while no significant correlation was observed in CRVO patients. In conclusion, multiplex bead system enabled a comprehensive soluble factor analysis in vitreous fluid derived from variety of patients. Major three factors: IL-6, IL-8, and MCP-1 were strongly correlated with each other indicating a common pathway involved in inflammation process in vitreoretinal diseases. FAU - Yoshimura, Takeru AU - Yoshimura T AD - Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. FAU - Sonoda, Koh-hei AU - Sonoda KH FAU - Sugahara, Mika AU - Sugahara M FAU - Mochizuki, Yasutaka AU - Mochizuki Y FAU - Enaida, Hiroshi AU - Enaida H FAU - Oshima, Yuji AU - Oshima Y FAU - Ueno, Akifumi AU - Ueno A FAU - Hata, Yasuaki AU - Hata Y FAU - Yoshida, Hiroki AU - Yoshida H FAU - Ishibashi, Tatsuro AU - Ishibashi T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091204 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Cytokines) RN - 0 (Inflammation Mediators) RN - 0 (Vascular Endothelial Growth Factor A) SB - IM MH - Aged MH - Cytokines/blood MH - Diabetic Retinopathy/blood/immunology/pathology MH - Female MH - Humans MH - Inflammation Mediators/blood/*metabolism MH - Male MH - Middle Aged MH - Models, Biological MH - Retinal Diseases/blood/*immunology/*pathology MH - Retinal Vein Occlusion/blood/immunology/pathology MH - Solubility MH - Vascular Endothelial Growth Factor A/blood MH - Vitreoretinopathy, Proliferative/blood/immunology/pathology MH - Vitreous Body/*immunology/*pathology PMC - PMC2780733 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2009/12/10 06:00 MHDA- 2010/03/18 06:00 PMCR- 2009/12/04 CRDT- 2009/12/10 06:00 PHST- 2009/06/25 00:00 [received] PHST- 2009/11/11 00:00 [accepted] PHST- 2009/12/10 06:00 [entrez] PHST- 2009/12/10 06:00 [pubmed] PHST- 2010/03/18 06:00 [medline] PHST- 2009/12/04 00:00 [pmc-release] AID - 09-PONE-RA-11504R1 [pii] AID - 10.1371/journal.pone.0008158 [doi] PST - epublish SO - PLoS One. 2009 Dec 4;4(12):e8158. doi: 10.1371/journal.pone.0008158.